Insider trades

Mark A. Goldsmith, Officer of Revolution Medicines RVMD, has filed 0 purchases and 55 sales on the open market. Over the past 12 months that comes to a net sale of $36.2M. The latest trade was on 06/16.

Mark A. Goldsmith

SEE REMARKS
First filing
23/02/23
Trades
117 trades
Buys / sales
0 / 55
12-month net buying
−$36.2M
Last trade
06/16

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan06/1606/1810,020 sh$156.12$1,564,322.4−3.6%
Open-market sale10b5-1 plan04/1504/17120,000 sh$150.09$18,010,800−30.2%
Open-market sale10b5-1 plan03/1703/1912,871 sh$99.48$1,280,407.08−4.4%
RVMD
Open-market sale10b5-1 plan03/0203/0336,000 sh13 trades$101.23avg.$3,644,280.2No record
Open-market sale10b5-1 plan25/12/1625/12/1815,394 sh$76.82$1,182,567.08−6.2%
RVMD
Open-market sale10b5-1 plan25/11/2525/11/2666,000 sh3 trades$75.07avg.$4,954,800No record
Open-market sale10b5-1 plan25/11/1825/11/2020,000 sh$70.38$1,407,600−7.5%
Open-market sale10b5-1 plan25/11/1225/11/1420,000 sh$65.07$1,301,400−7.5%
Open-market sale10b5-1 plan25/11/0725/11/1230,000 sh$60.31$1,809,300−7.9%
RVMD
Open-market sale10b5-1 plan25/10/16–25/10/1725/10/2020,000 sh2 trades$52.74avg.$1,054,700−4.2%
Open-market sale10b5-1 plan25/09/1625/09/1813,411 sh$45.82$614,492.02−2.9%
Open-market sale10b5-1 plan25/06/1625/06/1813,496 sh$39.83$537,545.68−3.1%
Open-market sale10b5-1 plan25/03/1725/03/1911,738 sh$39.04$458,251.52−2.6%
Open-market sale10b5-1 plan24/12/1624/12/1811,714 sh$45.40$531,815.6−3.5%
RVMD
Open-market sale10b5-1 plan24/11/01–24/11/0424/11/0570,000 sh4 trades$55.41avg.$3,878,936No record
Open-market sale10b5-1 plan24/10/1124/10/1530,000 sh$50.36$1,510,800−9.1%
RVMD
Open-market sale10b5-1 plan24/10/0124/10/0310,000 sh2 trades$44.93avg.$449,334.52−3.2%
Open-market sale10b5-1 plan24/09/1624/09/1811,715 sh$44.19$517,685.85−3.8%
RVMD
Open-market sale10b5-1 plan24/08/0124/08/0210,000 sh2 trades$45.88avg.$458,830.96−3.1%
RVMD
Open-market sale10b5-1 plan24/07/1224/07/1635,000 sh3 trades$45.04avg.$1,576,350No record